Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide versus metformin in overweight or obese women with polycystic ovary syndrome planning pregnancy
ChiCTR1900020516Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of exenatide and metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Pregnancy outcome, Weight and 1 more. Started Jan 2016; status: recruiting.
02
Drugs
exenatidemetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR1900020516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020516.